ECM
KURA icon

ExodusPoint Capital Management’s Kura Oncology KURA Stock Holding History

ExodusPoint Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
229,728
+205,175
+836% +$1.76M 0.01% 808
2025
Q4 		$255K Buy
24,553
+6,714
+38% +$70.4K ﹤0.01% 1347
2025
Q3 		$158K Buy
+17,839
New +$127K ﹤0.01% 1408
2025
Q2 		– Sell
-240,746
Closed -$1.59M – 1737
2025
Q1 		$1.59M Sell
240,746
-56,488
-19% -$440K 0.02% 778
2024
Q4 		$2.59M Buy
297,234
+242,263
+441% +$3.49M 0.02% 627
2024
Q3 		$1.07M Buy
+54,971
New +$1.11M 0.01% 954
2024
Q1 		– Sell
-39,349
Closed -$566K – 1743
2023
Q4 		$566K Sell
39,349
-1,960
-5% -$19.3K ﹤0.01% 1004
2023
Q3 		$377K Buy
41,309
+10,685
+35% +$108K ﹤0.01% 1334
2023
Q2 		$324K Sell
30,624
-86,810
-74% -$1.03M ﹤0.01% 1510
2023
Q1 		$1.44M Buy
117,434
+34,394
+41% +$429K 0.01% 1013
2022
Q4 		$1.03M Sell
83,040
-42,709
-34% -$621K 0.02% 927
2022
Q3 		$1.72M Buy
125,749
+73,419
+140% +$1.13M 0.02% 869
2022
Q2 		$959K Buy
52,330
+33,540
+178% +$482K 0.01% 1100
2022
Q1 		$302K Buy
+18,790
New +$271K ﹤0.01% 1754
2021
Q4 		– Sell
-19,581
Closed -$367K – 2399
2021
Q3 		$367K Buy
19,581
+9,109
+87% +$172K 0.01% 1536
2021
Q2 		$218K Buy
+10,472
New +$260K ﹤0.01% 1931
2021
Q1 		– Sell
-16,868
Closed -$551K – 2368
2020
Q4 		$551K Sell
16,868
-10,975
-39% -$386K 0.01% 1184
2020
Q3 		$853K Buy
27,843
+8,674
+45% +$192K 0.02% 753
2020
Q2 		$312K Buy
+19,169
New +$277K 0.01% 1299
2020
Q1 		– Sell
-10,773
Closed -$148K – 1381
2019
Q4 		$148K Buy
+10,773
New +$160K ﹤0.01% 1388

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's KURA Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Kura Oncology (KURA) stake by 836% in Q1 2026, buying an estimated $1.76M and bringing the position to 229,728 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #808.

ExodusPoint Capital Management first reported a position in KURA in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.59M in Q4 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • ExodusPoint Capital Management held 229,728 shares of Kura Oncology worth $1.87M as of Q1 2026.
  • ExodusPoint Capital Management bought 205,175 Kura Oncology shares in Q1 2026, an estimated $1.76M.
  • Kura Oncology made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #808 holding.
  • ExodusPoint Capital Management first reported a position in Kura Oncology in Q4 2019 and has held it in 20 quarters since.
  • ExodusPoint Capital Management's Kura Oncology position peaked at $2.59M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.